Summary: Retatrutide, an investigational GLP-1/GIP/glucagon triple agonist, most commonly causes gastrointestinal side effects, and no direct human fertility data currently exist, though indirect reproductive benefits via weight loss are plausible
3.2 Longacting GLP1 receptor agonists: once-daily 3.2.1 Lixisenatide LIXI is a once-daily GLP-1R agonist
Yang, U
With diet adjustments, lifestyle changes, and occasional medication, it rarely needs to stop treatment
General Principles of Retatrutide Injection In clinical practice, a Retatrutide medication is generally administered via subcutaneous injection, a method that delivers the compound into the fatty tissue layer beneath the skin for gradual absorption
Kidney and liver function Thyroid markers if indicated Body composition analysis (fat mass vs